Regulation of shRNA adenovirus construction by tumor specific promoter Survivin and inhibitory effect of Survivin on expression of CD133 gene in HepG-2 cells

LI Fang; ZOU Dongling; CAO Shu; LI Shaolin

您当前的位置：

首页 >

文章列表页 >

Regulation of shRNA adenovirus construction by tumor specific promoter Survivin and inhibitory effect of Survivin on expression of CD133 gene in HepG-2 cells

更新时间：2023-12-18

- Regulation of shRNA adenovirus construction by tumor specific promoter Survivin and inhibitory effect of Survivin on expression of CD133 gene in HepG-2 cells
- Journal of Chongqing Medical University Vol. 36, Issue 12, Pages: 1419-1424(2013)
- 作者机构：
  
  1. 重庆医科大学基础医学院放射医学教研室,重庆,400016
  2. 重庆市肿瘤医院妇产肿瘤科,重庆,400016
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2013，
扫描看全文
LI Fang, ZOU Dongling, CAO Shu, et al. Regulation of shRNA adenovirus construction by tumor specific promoter Survivin and inhibitory effect of Survivin on expression of CD133 gene in HepG-2 cells. [J]. Journal of Chongqing Medical University 36(12):1419-1424(2013)
DOI：

LI Fang, ZOU Dongling, CAO Shu, et al. Regulation of shRNA adenovirus construction by tumor specific promoter Survivin and inhibitory effect of Survivin on expression of CD133 gene in HepG-2 cells. [J]. Journal of Chongqing Medical University 36(12):1419-1424(2013) DOI：

摘要

目的：构建肿瘤特异性启动子Survivin驱动的小发夹RNA（shRNA），通过下调HepG-2肝癌细胞中CD133的表达，探讨其对肝癌细胞增殖和侵袭能力的影响。方法：①构建pEntr-Surp-shRNA真核表达载体，转染HepG-2肝癌细胞，Hela细胞，293T细胞。②设计shRNA干扰片段，筛选干扰最佳干扰效率的CD133干扰片段，重组载体pAd.Surp-shRNA972，pAd.Surp-shRNA2377，pAd.Surp-shRNA485并筛选出稳定表达shRNA的转染克隆。③Ad.Surp-shRNA972，Ad.Surp-shRNA2377，Ad.Surp-shRNA485腺病毒分别转染HepG-2肝癌细胞株，建立Ad.Surp-shRNA972，Ad.Surp-shRNA2377，Ad.Surp-shRNA485实验组，未转染腺病毒组为空白组。感染肝癌细胞株，应用RT-PCR和Western blot检测CD133 mRNA和蛋白的表达，MTT法和 Tran－swell 法检测细胞体外增殖和侵袭能力。结果：①成功构建了Survivin 启动子调控的shRNA真核表达载体pEntr-Surp-shRNA，在293T细胞株无荧光，而在Hela、HepG-2细胞株中荧光表达明显，证实Survivin具有肿瘤特异性。②成功包装Ad.Surp-shRNA972，Ad.Surp-shRNA2377，Ad.Surp-shRNA485腺病毒。③RT-PCR和Western blot检别显示Ad.Surp-shRNA972、Ad.Surp-shRNA2377，有封闭CD133 mRNA和蛋白表达的效果；计算实验组与空白组相比mRNA抑制率分别为（63.44±0.02）%、（56.98±0.03）%；Ad.Surp-shRNA972、Ad.Surp-shRNA2377、Ad.Surp-shRNA485组蛋白抑制率分别为（55.43±0.40）%、（48.65±0.20）%、（34.67±0.40）%；实验组细胞的增殖和侵袭能力也受到明显抑制，Ad.Surp-shRNA972组生长抑制率为（72.88±0.74）%，Ad.Surp-shRNA2377组生长抑制率为（59.90±0.87）%，Ad.Surp-shRNA485组生长抑制率为（30.18±0.95）%。结论：肿瘤特异性启动子Survivin调控腺病毒介导的shRNA能显著下调CD133基因的表达，抑制肝癌细胞株HepG-2的增值和减弱其侵袭力。

Abstract

Objective：To construct small hairpin RNA driven by tumor specific promoter Survivin and to discuss the effects of down-regulating CD133 expression in HepG-2 cells line on proliferative and invasive ability of hepatoma cell. Methods：①pEntr-Sur-shRNA eukaryotic expression vector was built and HepG-2 cells，Hela cells and 293T cells were transfected. ②shRNA interference fragments were designed and CD133 interference fragments with the best effect were screened out. Carriers were reconstructed；Ad.Surp-shRNA972，Ad.Surp-shRNA485，Ad.Surp-shRNA2377 adenovirus were packed；stable expression of shRNA transfection cloning was screened out 972，2377，485 experimental groups were established by transfecting HepG-2 cells with Ad.Surp-shRNA972，Ad.Surp-shRNA2377，Ad.Surp-shRNA485；untransfected group was taken as blank control group RT-PCR and Western blot were used to test CD133 mRNA and protein expression；MTT and Transwell method were used to detect the proliferative and invasive ability of cell in vitro. Results：①Survivin promoter regulated shRNA eukaryotic expression vector of pEntr-Sur-shRNA was successful con－structed. Fluorescence was seen in Hela and HepG-2 cells but not in 293T cells indicating tumor specificity of Survivin promoter. ②Adenovirus of Ad.Surp-shRNA972，Ad.Surp-shRNA2377 and Ad.Surp-shRNA485 were successfully packaged. ③According to results of RT-PCR and Western blot，mRNA and protein levels were inhibited significantly by Ad.Surp-shRNA972 and Ad.Surp-shRNA2377 mRNA inhibition rates were（63.44±0.02）% and （56.98±0.03）% in experiment group and blank group and protein inhibition rates were （55.43±0.40）%，（48.65±0.20）%，（34.67±0.4０）% in Ad.Surp-shRNA972 group，Ad.Surp-shRNA2377 group and Ad.Surp-shRNA485 group. Cell proliferative and invasive abilities of cells in experiment group were inhibited with inhibi－tion rates of （72.88±0.74）%，（59.9±0.87）% and （30.18±0.95）% in Ad.Surp-shRNA972 group，Ad.Surp-shRNA2377 group and Ad.Surp-shRNA485 group. Conclusions：Tumor specific promoter Survivin regulating adenovirus mediated shRNA can decrease CD133 suppression and inhibit proliferation and invasiveness of HepG-2 hepatoma cell.

关键词

SurvivinCD133小发夹RNA肝癌

Keywords

SurvivinCD133shRNAhepatoma

references

Views

945

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Molecular mechanism of Buzhong Yiqi Decoction in coordination with Siβ-catenin in intervention against cisplatin resistance in lung adenocarcinoma by regulating the Wnt/β-catenin signaling pathway

Activation of Wnt/β-catenin signaling pathway promotes anti-apoptotic genes bcl-2 and survivin expression in H9c2 cell subject to chronic hypoxia

Growth-inhibiting effects of Taxol on QGY cells:G₂/M arrests and apoptosis

A novel antiapoptosis gene,survivin,expression in bladder transitional cell cancer

Cloning and expression of survivin gene in eukaryotic cells

Related Author

Li He

Mu Qirui

Wang Zhe

Wang Ying

Yu Dan

Gao Yuan

Wang Haixia

Zhang Lei

Related Institution

Department of Pathology，College of Integrative Medicine，Liaoning University of Traditional Chinese Medicine

China International Science and Technology Cooperation Base of Child Development and Critical Disorders,Ministry of Education Key Laboratory of Child Development and Disorders,Chongqing Key Laboratory of Pediatrics

Department of Cardiology,Children’s Hospital of Chongqing Medical University

重庆医科大学第二临床学院消化内科

Department of Gastroenterology, the Second College of Clinical Medicine , Chongqing Medical University

⁰